- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/00 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
Patent holdings for IPC class C07D 263/00
Total number of patents in this class: 41
10-year publication summary
|
3
|
1
|
2
|
1
|
0
|
2
|
2
|
3
|
4
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Susos, AG | 12 |
2 |
| F. Hoffmann-La Roche AG | 7837 |
1 |
| BASF SE | 21303 |
1 |
| Merck Sharp & Dohme Corp. | 2183 |
1 |
| Syngenta Participations AG | 1524 |
1 |
| The Trustees of the University of Pennsylvania | 4415 |
1 |
| JSR Corporation | 2554 |
1 |
| Biovista, Inc. | 12 |
1 |
| Board of Trustees of Michigan State University | 1208 |
1 |
| CHDI Foundation, Inc. | 107 |
1 |
| Consejo Superior de Investigaciones Cientificas (csic) | 1443 |
1 |
| Eli Lilly and Company | 4101 |
1 |
| Fundacio Hospital Universitari Vall D'hebron - Institut de Recerca | 152 |
1 |
| The Hong Kong Polytechnic University | 527 |
1 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3335 |
1 |
| Korea Research Institute of Chemical Technology | 1469 |
1 |
| Mitsubishi Tanabe Pharma Corporation | 403 |
1 |
| Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences | 194 |
1 |
| Shiseido Company, Ltd. | 4259 |
1 |
| Socpra Sciences Sante et Humaines S.E.C. | 37 |
1 |
| Other owners | 20 |